Kaposi Sarcoma with Mucocutaneous Involvement in French Guiana: An Epidemiological Study between 1969 and 2019


  • Carl Lamoureux Department of Dermatology, Andrée-Rosemon Hospital, Cayenne, French Guiana
  • Kinan Drak Alsibai Department of Histopathology and Cytology, Andrée-Rosemon Hospital, Cayenne, French Guiana
  • Roger Pradinaud rogerpradinaud@orange.fr
  • Dominique Sainte-Marie dominique.sainte-marie@orange.fr
  • Pierre Couppie Department of Dermatology, Andrée-Rosemon Hospital, Cayenne, French Guiana
  • Romain Blaizot Dermatology Department, Andrée-Rosemon Hospital, Avenue des Flamboyants, 97300 Cayenne, French Guiana




Kaposi sarcoma, HHV8, Amerindians, Epidemiology, HIV, French Guiana


Data on Kaposi sarcoma in French Guiana are scarce and out of date. This territory presents unique epidemiological features. The objectives of this retrospective study were to analyse the clinical features, outcome and incidence of the different forms of Kaposi sarcoma in patients diagnosed between 1969 and 2019. The study population comprised a total of 52 patients. Clinical forms included epidemic Kaposi sarcoma (n=30), endemic (n=18), iatrogenic (n=2), classic (n=1) and unclassified Kaposi sarcoma (n=1). The mean annual incidence rate of epidemic Kaposi reached a peak in the 1990s (0.93/100,000) then decreased in the 2000s (0.33/100,000), while the incidence of endemic Kaposi sarcoma reached a peak in the 1980s (0.82/100,000) before decreasing in the 2000s (0.12/100,000). Factors associated with the epidemic form were: sexual intercourse between men (p=0.0054) and Haitian origin (p=0.035). The presence of nodules and/or tumour, lesions limited to the lower limbs, and age >65 years were associated with the endemic form. While Creole populations seem to be as affected by endemic Kaposi sarcoma as their African counterparts, the dynamics of Kaposi sarcoma in French Guiana are now dominated by the epidemic form.


Download data is not yet available.


Kaposi M. [Multiple idiopathic pigmented sarcoma] Idiopathisches multiples Pigmentsarkom der. Arch Dermatol Syph (Prague) 1872; 4: 265-273.

https://doi.org/10.1007/BF01830024 DOI: https://doi.org/10.1007/BF01830024

Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi sarcoma. Science 1994; 266: 1865-1869.

https://doi.org/10.1126/science.7997879 DOI: https://doi.org/10.1126/science.7997879

Camain R. Sur un cas de maladie de Kaposi en Guyane française. Rev Coloniale Med Chir 1949; 21: 36-38.

Thomas P, Pradinaud R, Sainte-Marie D, Degavre B. La maladie de Kaposi en Guyane Française: aspects épidémiologiques, cliniques et thérapeutiques. Les Nouvelles Dermatologiques 1991; 10: 486-488.

Plancoulaine S, Abel L, van Beveren M, Trégouët DA, Joubert M, Tortevoye P, et al. Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population. Lancet 2000; 356: 1062-1065.

https://doi.org/10.1016/S0140-6736(00)02729-X DOI: https://doi.org/10.1016/S0140-6736(00)02729-X

Plancoulaine S, Abel L, van Beveren M, Gessain A. High titers of anti-human herpesvirus 8 antibodies in elderly males in an endemic population. J Natl Cancer Inst 2002; 94: 1333-1335.

https://doi.org/10.1093/jnci/94.17.1333 DOI: https://doi.org/10.1093/jnci/94.17.1333

Kazanji M, Dussart P, Duprez R, Tortevoye P, Pouliquen J-F, Vandekerkhove J, et al. Serological and molecular evidence that human herpesvirus 8 is endemic among amerindians in French Guiana. J Infect Dis 2005; 192: 1525-1529.

https://doi.org/10.1086/491744 DOI: https://doi.org/10.1086/491744

Liu Z, Fang Q, Zuo J, Minhas V, Wood C, Zhang T. The world-wide incidence of Kaposi sarcoma in the HIV/AIDS era. HIV Medicine 2018; 19: 355-364.

https://doi.org/10.1111/hiv.12584 DOI: https://doi.org/10.1111/hiv.12584

Marcoval J, Bonfill-Ortí M, Martínez-Molina L, Valentí-Medina F, Penín RM, Servitje O. Evolution of Kaposi sarcoma in the past 30 years in a tertiary hospital of the European Mediterranean basin. Clin Exp Dermatol 2019; 44: 32-39.

https://doi.org/10.1111/ced.13605 DOI: https://doi.org/10.1111/ced.13605

Nacher M, Vantilcke V, Parriault MC, Van Melle A, Hanf M, Labadie G, et al. What is driving the HIV epidemic in French Guiana? Int J STD AIDS 2010; 21: 359-361.

https://doi.org/10.1258/ijsa.2010.009570 DOI: https://doi.org/10.1258/ijsa.2010.009570

Nacher M, Ouedraogo E, Djossou F, Elenga N, Adonis A, Couppie P et al. HIV in French Guiana: historical review and current trends. The major health problems in Guyana in 2020: three examples of pathologies. BEH 2-3, January 2020.

Nacher M, Adriouch L, Huber F, Vantilcke V, Djossou F, Elenga N, et al. Modeling of the HIV epidemic and continuum of care in French Guiana. PLoS One 2018; 13: e0197990.

https://doi.org/10.1371/journal.pone.0197990 DOI: https://doi.org/10.1371/journal.pone.0197990

Etemad SA, Dewan AK. Kaposi sarcoma updates. Dermatol Clin 2019; 37: 505-517.

https://doi.org/10.1016/j.det.2019.05.008 DOI: https://doi.org/10.1016/j.det.2019.05.008

Lebbe C, Garbe C, Stratigos AJ, Harwood C, Peris K, Del Marmol V, et al. Diagnosis and treatment of Kaposi sarcoma: European consensus-based interdisciplinary guideline (EDF/EADO/EORTC). Eur J Cancer 2019; 114: 117-127.

https://doi.org/10.1016/j.ejca.2018.12.036 DOI: https://doi.org/10.1016/j.ejca.2018.12.036

Schwartz RA, Micali G, Nasca MR, Scuderi L. Kaposi sarcoma: a continuing conundrum. J Am Acad Dermatol 2008; 59: 179-206; quiz 207-208.

https://doi.org/10.1016/j.jaad.2008.05.001 DOI: https://doi.org/10.1016/j.jaad.2008.05.001

Patel RM, Goldblum JR, Hsi ED. Immunohistochemical detection of human herpes virus-8 latent nuclear antigen-1 is useful in the diagnosis of Kaposi sarcoma. Mod Pathol 2004; 17: 456-460.

https://doi.org/10.1038/modpathol.3800061 DOI: https://doi.org/10.1038/modpathol.3800061

Wu X-J, Pu X-M, Kang X-J, Halifu Y, An C-X, Zhang D-Z, et al. One hundred and five Kaposi sarcoma patients: a clinical study in Xinjiang, Northwest of China. J Eur Acad Dermatol Venereol 2014; 28: 1545-1552.

https://doi.org/10.1111/jdv.12349 DOI: https://doi.org/10.1111/jdv.12349

Lanoy E, Spano J-P, Bonnet F, Guiguet M, Boué F, Cadranel J, et al. The spectrum of malignancies in HIV-infected patients in 2006 in France: the ONCOVIH study. Int J Cancer 2011; 129: 467-475.

https://doi.org/10.1002/ijc.25903 DOI: https://doi.org/10.1002/ijc.25903

Mohanna S, Maco V, Bravo F, Gotuzzo E. Epidemiology and clinical characteristics of classic Kaposi sarcoma, seroprevalence, and variants of human herpesvirus 8 in South America: a critical review of an old disease. Int J Infect Dis 2005; 9: 239-250.

https://doi.org/10.1016/j.ijid.2005.02.004 DOI: https://doi.org/10.1016/j.ijid.2005.02.004

Fouchard N, Lacoste V, Couppie P, Develoux M, Mauclere P, Michel P, et al. Detection and genetic polymorphism of human herpes virus type 8 in endemic or epidemic Kaposi sarcoma from West and Central Africa, and South America. Int J Cancer 2000; 85: 166-170. DOI: https://doi.org/10.1002/(SICI)1097-0215(20000115)85:2<166::AID-IJC3>3.0.CO;2-L


Lacoste V, Judde JG, Brière J, Tulliez M, Garin B, Kassa-Kelembho E, et al. Molecular epidemiology of human herpesvirus 8 in Africa: both B and A5 K1 genotypes, as well as the M and P genotypes of K14.1/K15 loci, are frequent and widespread. Virology 2000; 278: 60-74.

https://doi.org/10.1006/viro.2000.0629 DOI: https://doi.org/10.1006/viro.2000.0629

D'Oliveira JJ, Torres FO. Kaposi's sarcoma in the Bantu of Mozambique. Cancer 1972; 30: 553-561.

https://doi.org/10.1002/1097-0142(197208)30:2<553::AID-CNCR2820300236>3.0.CO;2-W DOI: https://doi.org/10.1002/1097-0142(197208)30:2<553::AID-CNCR2820300236>3.0.CO;2-W

Friedman-Kien AE, Saltzman BR. Clinical manifestations of classical, endemic African, and epidemic AIDS-associated Kaposi's sarcoma. J Am Acad Dermatol 1990; 22: 1237-1250.

https://doi.org/10.1016/0190-9622(90)70169-I DOI: https://doi.org/10.1016/0190-9622(90)70169-I

Weissmann A, Linn S, Weltfriend S, Friedman-Birnbaum R. Epidemiological study of classic Kaposi sarcoma: a retrospective review of 125 cases from Northern Israel. J Eur Acad Dermatol Venereol 2000; 14: 91-95.

https://doi.org/10.1046/j.1468-3083.2000.00022.x DOI: https://doi.org/10.1046/j.1468-3083.2000.00022.x

Kluger N, Blomqvist C, Kivelä P. Kaposi sarcoma in Southern Finland (2006-2018). Int J Dermatol 2019; 58: 1258-1263.

https://doi.org/10.1111/ijd.14563 DOI: https://doi.org/10.1111/ijd.14563

Klepp O, Dahl O, Stenwig JT. Association of Kaposi sarcoma and prior immunosuppressive therapy: a 5-year material of Kaposi sarcoma in Norway. Cancer 1978; 42: 2626-2630.

https://doi.org/10.1002/1097-0142(197812)42:6<2626::AID-CNCR2820420618>3.0.CO;2-7 DOI: https://doi.org/10.1002/1097-0142(197812)42:6<2626::AID-CNCR2820420618>3.0.CO;2-7

Stallone G, Schena A, Infante B, Di Paolo S, Loverre A, Maggio G, et al. Sirolimus for Kaposi sarcoma in renal-transplant recipients. N Engl J Med 2005; 352: 1317-1323.

https://doi.org/10.1056/NEJMoa042831 DOI: https://doi.org/10.1056/NEJMoa042831

Delyon J, Rabate C, Euvrard S, Harwood CA, Proby C, Güleç AT, et al. Management of Kaposi sarcoma after solid organ transplantation: a European retrospective study. J Am Acad Dermatol 2019; 81: 448-455.

https://doi.org/10.1016/j.jaad.2019.03.028 DOI: https://doi.org/10.1016/j.jaad.2019.03.028

Fay DE, Nisbeth H. Massive gastrointestinal hemorrhage in an immunosuppressed man due to gastric Kaposi sarcoma. Am J Gastroenterol 1990; 85: 607-609.

Sáinz-Gil M, Rodríguez-Jiménez P, Cárdaba ME, Martín Arias LH. Kaposi sarcoma in patients on tumour necrosis factor alpha inhibitors: a case-noncase study. J Eur Acad Dermatol Venereol 2020; 34: e156-e158.

https://doi.org/10.1111/jdv.16087 DOI: https://doi.org/10.1111/jdv.16087

Laresche C, Fournier E, Dupond AS, Woronoff AS, Drobacheff-Thiebaut C, Humbert P, Aubin F. Kaposi sarcoma: a population-based cancer registry descriptive study of 57 consecutive cases diagnosed between 1977 and 2009. Int J Dermatol 2014; 53: e549-554.

https://doi.org/10.1111/ijd.12453 DOI: https://doi.org/10.1111/ijd.12453

Cox FH, Helwig EB. Kaposi sarcoma. Cancer 1959; 12: 289-298.

https://doi.org/10.1002/1097-0142(195903/04)12:2<289::AID-CNCR2820120213>3.0.CO;2-Z DOI: https://doi.org/10.1002/1097-0142(195903/04)12:2<289::AID-CNCR2820120213>3.0.CO;2-Z

Maurer T, Ponte M, Leslie K. HIV-associated Kaposi sarcoma with a high CD4 count and a low viral load. N Engl J Med 2007; 357: 1352-1353

https://doi.org/10.1056/NEJMc070508 DOI: https://doi.org/10.1056/NEJMc070508

Chapalain M, Goldman-Lévy G, Kramkimel N, Carlotti A, Franck N, Lheure C, et al. Anaplastic Kaposi sarcoma: 5 cases of a rare and aggressive type of Kaposi sarcoma. Ann Dermatol Venereol 2018; 145: 21-28.

https://doi.org/10.1016/j.annder.2017.09.593 DOI: https://doi.org/10.1016/j.annder.2017.09.593

Denis D, Seta V, Regnier-Rosencher E, Kramkimel N, Chanal J, Avril M-F, Dupin N. A fifth subtype of Kaposi sarcoma, classic Kaposi sarcoma in men who have sex with men: a cohort study in Paris. J Eur Acad Dermatol Venereol 2018; 32: 1377-1384.

https://doi.org/10.1111/jdv.14831 DOI: https://doi.org/10.1111/jdv.14831



How to Cite

Lamoureux, C., Drak Alsibai, K., Pradinaud, R., Sainte-Marie, D., Couppie, P., & Blaizot, R. (2022). Kaposi Sarcoma with Mucocutaneous Involvement in French Guiana: An Epidemiological Study between 1969 and 2019. Acta Dermato-Venereologica, 102, adv00709. https://doi.org/10.2340/actadv.v102.581

Most read articles by the same author(s)